文献速递肝病

卵泡抑素调控的激活素-HNF4α-凝血因子轴决定急性肝衰竭结局

Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.
PubMed 文献 · Hepatology · 2021-12-14

本研究探讨急性肝衰竭(ALF)患者肝祖细胞(LPC)中HNF4α及其调控因子和靶点表达如何决定临床结局。在19例ALF患者中,恢复者LPC或残留肝细胞高表达HNF4α,且LPC中激活素/卵泡抑素比值正常、pSmad2和HNF4α丰富,凝血功能显著改善;卵泡抑素由胰岛素和胰高血糖素调控。随访186例肝硬化患者80个月提示血清卵泡抑素水平可预测慢加急性肝衰竭的发生率和死亡率。

要点

  • ALF恢复者LPC中HNF4α高表达,通过结合启动子调控凝血因子表达。
  • 卵泡抑素负向调控激活素信号,恢复者激活素/卵泡抑素比值正常。
  • 血清卵泡抑素水平可预测肝硬化患者慢加急性肝衰竭发生和死亡。

核心结论

  • 卵泡抑素调控的激活素-HNF4α-凝血因子轴在决定大量肝细胞丢失所致ALF的临床结局中起关键作用。
  • 胰岛素和胰高血糖素对卵泡抑素的影响提示全身代谢状态在ALF中起重要作用。

研究设计与样本

  • 对19例ALF患者(9例恢复,10例接受肝移植)进行临床病理关联分析。
  • 体外实验和甲硝唑处理的斑马鱼中研究卵泡抑素、激活素、HNF4α与凝血因子表达的调控机制。
  • 前瞻性临床研究随访186例肝硬化患者80个月,观察卵泡抑素水平与慢加急性肝衰竭患病率和死亡率的关系。

主要发现

  • 恢复的ALF患者在LPC或残留肝细胞中均强烈表达HNF4α。
  • LPC中HNF4α通过结合凝血因子启动子控制其表达。
  • LPC中HNF4α表达需要FoxH1-Smad2/3/4转录因子复合物,该复合物由TGF-β超家族成员激活素促进。
  • LPC中激活素信号受卵泡抑素负向调控,卵泡抑素是受胰岛素和胰高血糖素控制的肝细胞来源激素。
  • 与需肝移植患者相比,恢复者显示正常激活素/卵泡抑素比值、LPC中pSmad2和HNF4α丰富,凝血功能显著改善。

临床怎么用

  • 血清卵泡抑素水平可能用于预测肝硬化患者慢加急性肝衰竭的发生和死亡风险。
  • ALF中激活素/卵泡抑素比值及LPC中HNF4α表达状态可能有助于判断预后。
  • 全身代谢状态(胰岛素和胰高血糖素)对卵泡抑素的调控提示代谢管理在ALF中的潜在重要性。

局限性

  • ALF临床病理关联分析样本量较小(19例)。
  • 机制研究主要基于体外实验和斑马鱼模型,需进一步在人体中验证。
  • 卵泡抑素预测慢加急性肝衰竭的结论来自随访研究,需更多前瞻性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: In patients with acute liver failure (ALF) who suffer from massive hepatocyte loss, liver progenitor cells (LPCs) take over key hepatocyte functions, which ultimately determines survival. This study investigated how the expression of hepatocyte nuclear factor 4α (HNF4α), its regulators, and targets in LPCs determines clinical outcome of patients with ALF. APPROACH AND RESULTS: Clinicopathological associations were scrutinized in 19 patients with ALF (9 recovered and 10 receiving liver transplantation). Regulatory mechanisms between follistatin, activin, HNF4α, and coagulation factor expression in LPC were investigated in vitro and in metronidazole-treated zebrafish. A prospective clinical study followed up 186 patients with cirrhosis for 80 months to observe the relevance of follistatin levels in prevalence and mortality of acute-on-chronic liver failure. Recovered patients with ALF robustly express HNF4α in either LPCs or remaining hepatocytes. As in hepatocytes, HNF4α controls the expression of coagulation factors by binding to their promoters in LPC. HNF4α expression in LPCs requires the forkhead box protein H1-Sma and Mad homolog 2/3/4 transcription factor complex, which is promoted by the TGF-β superfamily member activin. Activin signaling in LPCs is negatively regulated by follistatin, a hepatocyte-derived hormone controlled by insulin and glucagon. In contrast to patients requiring liver transplantation, recovered patients demonstrate a normal activin/follistatin ratio, robust abundance of the activin effectors phosphorylated Sma and Mad homolog 2 and HNF4α in LPCs, leading to significantly improved coagulation function. A follow-up study indicated that serum follistatin levels could predict the incidence and mortality of acute-on-chronic liver failure. CONCLUSIONS: These results highlight a crucial role of the follistatin-controlled activin-HNF4α-coagulation axis in determining the clinical outcome of massive hepatocyte loss-induced ALF. The effects of insulin and glucagon on follistatin suggest a key role of the systemic metabolic state in ALF.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lin T, Wang S, Munker S, et al. Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. Hepatology. 2021. PMID: 34435364. doi:10.1002/hep.32119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。